vs

Side-by-side financial comparison of EMCOR Group, Inc. (EME) and Emerson Electric (EMR). Click either name above to swap in a different company.

EMCOR Group, Inc. is the larger business by last-quarter revenue ($4.5B vs $4.3B, roughly 1.0× Emerson Electric). Emerson Electric runs the higher net margin — 13.9% vs 9.6%, a 4.3% gap on every dollar of revenue. On growth, EMCOR Group, Inc. posted the faster year-over-year revenue change (19.7% vs 4.1%). Emerson Electric produced more free cash flow last quarter ($602.0M vs $492.5M). Over the past eight quarters, EMCOR Group, Inc.'s revenue compounded faster (14.7% CAGR vs -0.3%).

EMCOR Group, Inc., is an engineering, construction, and property management company headquartered in Norwalk, Connecticut.

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

EME vs EMR — Head-to-Head

Bigger by revenue
EME
EME
1.0× larger
EME
$4.5B
$4.3B
EMR
Growing faster (revenue YoY)
EME
EME
+15.6% gap
EME
19.7%
4.1%
EMR
Higher net margin
EMR
EMR
4.3% more per $
EMR
13.9%
9.6%
EME
More free cash flow
EMR
EMR
$109.5M more FCF
EMR
$602.0M
$492.5M
EME
Faster 2-yr revenue CAGR
EME
EME
Annualised
EME
14.7%
-0.3%
EMR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
EME
EME
EMR
EMR
Revenue
$4.5B
$4.3B
Net Profit
$434.6M
$605.0M
Gross Margin
19.7%
53.2%
Operating Margin
12.7%
17.8%
Net Margin
9.6%
13.9%
Revenue YoY
19.7%
4.1%
Net Profit YoY
48.8%
3.4%
EPS (diluted)
$9.64
$1.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EME
EME
EMR
EMR
Q4 25
$4.5B
$4.3B
Q3 25
$4.3B
$4.9B
Q2 25
$4.3B
$4.6B
Q1 25
$3.9B
$4.4B
Q4 24
$3.8B
$4.2B
Q3 24
$3.7B
$4.6B
Q2 24
$3.7B
$4.4B
Q1 24
$3.4B
$4.4B
Net Profit
EME
EME
EMR
EMR
Q4 25
$434.6M
$605.0M
Q3 25
$295.4M
$637.0M
Q2 25
$302.2M
$586.0M
Q1 25
$240.7M
$485.0M
Q4 24
$292.2M
$585.0M
Q3 24
$270.3M
$996.0M
Q2 24
$247.6M
$329.0M
Q1 24
$197.1M
$501.0M
Gross Margin
EME
EME
EMR
EMR
Q4 25
19.7%
53.2%
Q3 25
19.4%
51.9%
Q2 25
19.4%
52.6%
Q1 25
18.7%
53.5%
Q4 24
20.1%
53.5%
Q3 24
19.9%
51.3%
Q2 24
18.7%
52.8%
Q1 24
17.2%
52.2%
Operating Margin
EME
EME
EMR
EMR
Q4 25
12.7%
17.8%
Q3 25
9.4%
16.4%
Q2 25
9.6%
16.1%
Q1 25
8.2%
14.2%
Q4 24
10.3%
18.6%
Q3 24
9.8%
14.7%
Q2 24
9.1%
10.4%
Q1 24
7.6%
16.2%
Net Margin
EME
EME
EMR
EMR
Q4 25
9.6%
13.9%
Q3 25
6.9%
13.1%
Q2 25
7.0%
12.9%
Q1 25
6.2%
10.9%
Q4 24
7.7%
14.0%
Q3 24
7.3%
21.6%
Q2 24
6.8%
7.5%
Q1 24
5.7%
11.4%
EPS (diluted)
EME
EME
EMR
EMR
Q4 25
$9.64
$1.07
Q3 25
$6.57
$1.12
Q2 25
$6.72
$1.04
Q1 25
$5.26
$0.86
Q4 24
$6.30
$1.02
Q3 24
$5.80
$1.74
Q2 24
$5.25
$0.57
Q1 24
$4.17
$0.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EME
EME
EMR
EMR
Cash + ST InvestmentsLiquidity on hand
$1.1B
Total DebtLower is stronger
$7.6B
Stockholders' EquityBook value
$3.7B
$20.3B
Total Assets
$9.3B
$41.9B
Debt / EquityLower = less leverage
0.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EME
EME
EMR
EMR
Q4 25
$1.1B
Q3 25
$655.1M
Q2 25
$486.0M
Q1 25
$576.7M
Q4 24
$1.3B
Q3 24
$1.0B
Q2 24
$807.3M
Q1 24
$841.0M
Total Debt
EME
EME
EMR
EMR
Q4 25
$7.6B
Q3 25
$8.9B
Q2 25
$8.3B
Q1 25
$8.2B
Q4 24
$6.6B
Q3 24
$7.7B
Q2 24
$7.1B
Q1 24
$7.6B
Stockholders' Equity
EME
EME
EMR
EMR
Q4 25
$3.7B
$20.3B
Q3 25
$3.3B
$20.3B
Q2 25
$3.1B
$19.9B
Q1 25
$2.9B
$19.2B
Q4 24
$2.9B
$20.5B
Q3 24
$2.8B
$21.6B
Q2 24
$2.7B
$20.8B
Q1 24
$2.6B
$20.9B
Total Assets
EME
EME
EMR
EMR
Q4 25
$9.3B
$41.9B
Q3 25
$8.6B
$42.0B
Q2 25
$8.4B
$42.5B
Q1 25
$8.1B
$42.0B
Q4 24
$7.7B
$42.6B
Q3 24
$7.3B
$44.2B
Q2 24
$7.1B
$45.6B
Q1 24
$6.7B
$46.4B
Debt / Equity
EME
EME
EMR
EMR
Q4 25
0.37×
Q3 25
0.44×
Q2 25
0.42×
Q1 25
0.42×
Q4 24
0.32×
Q3 24
0.36×
Q2 24
0.34×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EME
EME
EMR
EMR
Operating Cash FlowLast quarter
$524.4M
$699.0M
Free Cash FlowOCF − Capex
$492.5M
$602.0M
FCF MarginFCF / Revenue
10.9%
13.9%
Capex IntensityCapex / Revenue
0.7%
2.2%
Cash ConversionOCF / Net Profit
1.21×
1.16×
TTM Free Cash FlowTrailing 4 quarters
$1.2B
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EME
EME
EMR
EMR
Q4 25
$524.4M
$699.0M
Q3 25
$475.5M
$3.1B
Q2 25
$193.7M
$1.1B
Q1 25
$108.5M
$241.0M
Q4 24
$469.5M
$777.0M
Q3 24
$526.4M
$3.3B
Q2 24
$279.7M
$1.1B
Q1 24
$132.3M
$743.0M
Free Cash Flow
EME
EME
EMR
EMR
Q4 25
$492.5M
$602.0M
Q3 25
$448.8M
$2.7B
Q2 25
$165.6M
$977.0M
Q1 25
$82.3M
$154.0M
Q4 24
$451.8M
$694.0M
Q3 24
$508.7M
$2.9B
Q2 24
$260.4M
$998.0M
Q1 24
$112.0M
$661.0M
FCF Margin
EME
EME
EMR
EMR
Q4 25
10.9%
13.9%
Q3 25
10.4%
54.9%
Q2 25
3.8%
21.5%
Q1 25
2.1%
3.5%
Q4 24
12.0%
16.6%
Q3 24
13.8%
63.1%
Q2 24
7.1%
22.8%
Q1 24
3.3%
15.1%
Capex Intensity
EME
EME
EMR
EMR
Q4 25
0.7%
2.2%
Q3 25
0.6%
8.9%
Q2 25
0.7%
2.0%
Q1 25
0.7%
2.0%
Q4 24
0.5%
2.0%
Q3 24
0.5%
9.1%
Q2 24
0.5%
2.1%
Q1 24
0.6%
1.9%
Cash Conversion
EME
EME
EMR
EMR
Q4 25
1.21×
1.16×
Q3 25
1.61×
4.86×
Q2 25
0.64×
1.83×
Q1 25
0.45×
0.50×
Q4 24
1.61×
1.33×
Q3 24
1.95×
3.35×
Q2 24
1.13×
3.31×
Q1 24
0.67×
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EME
EME

Segment breakdown not available.

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

Related Comparisons